Mitesh

In response to a significant ongoing disruption to the supply of Venlafaxine 37.5mg modified-release tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 23rd June 2025, SSP083, provides that for every Venlafaxine 37.5mg modified-release tablet originally prescribed one Venlafaxine 37.5mg modified-release capsule must be supplied. SSP083, [...]

The post SSP for Venlafaxine 37.5mg modified-release tablets issued appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches MSN/2025/038 Tier 2 – medium impact Date of issue: 19/06/2025 Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour and 70micrograms/hour transdermal patches are out of stock until early August [...]

The post Medicine Supply Notification: Buprenorphine (Relevtec®) 35micrograms/hour, 52.5micrograms/hour, 70micrograms/hour transdermal patches Buprenorphine (Bupeaze®) 52.5micrograms/hour transdermal patches appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Venlafaxine 37.5mg modified-release tablets. MSN/2025/035 Tier 2 – medium impact Date of issue: 13th June 2025 Venlafaxine 37.5mg modified release (MR) tablets are out of stock until mid-July 2025. Venlafaxine 37.5mg MR capsules remain available and can support increased demand. Venlafaxine [...]

The post Medicine Supply Notification: Venlafaxine 37.5mg modified-release tablets appeared first on Community Pharmacy England.

Update 24/07/2025 – Latest update on branded stock availability (as of 24/07/2025) and addition of Premique® Low Dose 0.3mg/1.5mg modified-release tablets to the table below. Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released [...]

The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.